BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22017796)

  • 1. The amplifier effect: how Pin1 empowers mutant p53.
    Hu H; Wulf GM
    Breast Cancer Res; 2011 Oct; 13(5):315. PubMed ID: 22017796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wiring the oncogenic circuitry: Pin1 unleashes mutant p53.
    Napoli M; Girardini JE; Piazza S; Del Sal G
    Oncotarget; 2011 Sep; 2(9):654-6. PubMed ID: 21926448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Pin1/mutant p53 axis promotes aggressiveness in breast cancer.
    Girardini JE; Napoli M; Piazza S; Rustighi A; Marotta C; Radaelli E; Capaci V; Jordan L; Quinlan P; Thompson A; Mano M; Rosato A; Crook T; Scanziani E; Means AR; Lozano G; Schneider C; Del Sal G
    Cancer Cell; 2011 Jul; 20(1):79-91. PubMed ID: 21741598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP.
    Mantovani F; Tocco F; Girardini J; Smith P; Gasco M; Lu X; Crook T; Del Sal G
    Nat Struct Mol Biol; 2007 Oct; 14(10):912-20. PubMed ID: 17906639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KeePin' the p53 family in good shape.
    Mantovani F; Gostissa M; Collavin L; Del Sal G
    Cell Cycle; 2004 Jul; 3(7):905-11. PubMed ID: 15254434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decursin exerts anti-cancer activity in MDA-MB-231 breast cancer cells via inhibition of the Pin1 activity and enhancement of the Pin1/p53 association.
    Kim JH; Jung JH; Kim SH; Jeong SJ
    Phytother Res; 2014 Feb; 28(2):238-44. PubMed ID: 23580332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prolyl-isomerase Pin1 activates the mitochondrial death program of p53.
    Sorrentino G; Mioni M; Giorgi C; Ruggeri N; Pinton P; Moll U; Mantovani F; Del Sal G
    Cell Death Differ; 2013 Feb; 20(2):198-208. PubMed ID: 22935610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prolyl isomerase Pin1 enhances HER-2 expression and cellular transformation via its interaction with mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1.
    Khanal P; Namgoong GM; Kang BS; Woo ER; Choi HS
    Mol Cancer Ther; 2010 Mar; 9(3):606-16. PubMed ID: 20179161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults.
    Zacchi P; Gostissa M; Uchida T; Salvagno C; Avolio F; Volinia S; Ronai Z; Blandino G; Schneider C; Del Sal G
    Nature; 2002 Oct; 419(6909):853-7. PubMed ID: 12397362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response.
    Zheng H; You H; Zhou XZ; Murray SA; Uchida T; Wulf G; Gu L; Tang X; Lu KP; Xiao ZX
    Nature; 2002 Oct; 419(6909):849-53. PubMed ID: 12397361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis.
    Wulf G; Garg P; Liou YC; Iglehart D; Lu KP
    EMBO J; 2004 Aug; 23(16):3397-407. PubMed ID: 15257284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 Retards cell-growth and suppresses etoposide-induced apoptosis in Pin1-deficient mouse embryonic fibroblasts.
    Shimazaki K; Uchida T; Komine A; Takahashi K
    Biochem Biophys Res Commun; 2012 May; 422(1):133-8. PubMed ID: 22564744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The loss of PIN1 deregulates cyclin E and sensitizes mouse embryo fibroblasts to genomic instability.
    Yeh ES; Lew BO; Means AR
    J Biol Chem; 2006 Jan; 281(1):241-51. PubMed ID: 16223725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prolyl isomerase Pin1 in breast development and cancer.
    Wulf G; Ryo A; Liou YC; Lu KP
    Breast Cancer Res; 2003; 5(2):76-82. PubMed ID: 12631385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed-lineage kinase 3 phosphorylates prolyl-isomerase Pin1 to regulate its nuclear translocation and cellular function.
    Rangasamy V; Mishra R; Sondarva G; Das S; Lee TH; Bakowska JC; Tzivion G; Malter JS; Rana B; Lu KP; Kanthasamy A; Rana A
    Proc Natl Acad Sci U S A; 2012 May; 109(21):8149-54. PubMed ID: 22566623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer.
    Ryo A; Liou YC; Lu KP; Wulf G
    J Cell Sci; 2003 Mar; 116(Pt 5):773-83. PubMed ID: 12571275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting peptidyl-prolyl isomerase pin1 to inhibit tumor cell aggressiveness.
    Beretta GL; De Cesare M; Albano L; Magnifico A; Carenini N; Corna E; Perego P; Gatti L
    Tumori; 2016; 102(2):144-9. PubMed ID: 26917410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 Regulation: a family affair.
    Haupt Y
    Cell Cycle; 2004 Jul; 3(7):884-5. PubMed ID: 15190198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Death-associated protein kinase 1 phosphorylates Pin1 and inhibits its prolyl isomerase activity and cellular function.
    Lee TH; Chen CH; Suizu F; Huang P; Schiene-Fischer C; Daum S; Zhang YJ; Goate A; Chen RH; Zhou XZ; Lu KP
    Mol Cell; 2011 Apr; 42(2):147-59. PubMed ID: 21497122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinoma.
    Teng BL; Hacker KE; Chen S; Means AR; Rathmell WK
    Mol Oncol; 2011 Oct; 5(5):465-74. PubMed ID: 21764651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.